This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T et al.; European Association of Urology: EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014; 65: 124–137.10.1016/j.eururo.2013.09.046Search in Google Scholar
Koya MP, Simon MA, Soloway MS: Complications of intravesical therapy forurothelial cancer of the bladder. J Urol 2006; 175: 2004–2010.10.1016/S0022-5347(06)00264-3Search in Google Scholar
Leibovici D, Zisman A, Chen-Levyi Z, Cypele H, Siegel YI, Faitelovich S et al.: Elevated prostate specific antigen serum levels after intravesical instillation of bacillus Calmette-Guerin. J Urol 2000; 164: 1546–1549.10.1016/S0022-5347(05)67025-5Search in Google Scholar
LaFontaine PD, Middleman BR, Graham SD Jr, Sanders WH: Incidence of granulomatous prostatitis and acid-fast bacilli after intravesical BCG therapy. Urology 1997; 49: 363–366.10.1016/S0090-4295(96)00507-9Search in Google Scholar
Joaquim A, Custódio S, Pimentel FL, Matos JF,Peixoto V, Faria AL et al.: Bacillary prostatitis after intravesical immunotherapy: a rare adverse effect. Case Rep Oncol 2012; 5: 80–83.10.1159/000336445333773622539919Search in Google Scholar
Szopiński T, Nowicki A, Zátura F, Gołąbek T, Chłosta P: Novel trends in transrectal ultrasound imaging of prostate gland carcinoma. J Ultrason 2014; 14: 306–319.10.15557/JoU.2014.0031457969126676141Search in Google Scholar
